Global University Venturing

Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.

Stanford spinout Bolt Biotherapeutics has raised more than twice as much as originally planned in an offering that also provided exits for corporates Pfizer, Novo and Fan Fung.

Immunocore has raised more than $258m in an upsized offering and an additional $15m in a concurrent private placement.

Harvard-linked Sana brought in nearly four times as much in proceeds as originally planned and saw shares surge 40% on the first day of trading.

Fraunhofer Society has participated in a series B round for its solar wafer technology spinout, which also attracted Saudi Aramco.

Virginia Tech spinout Landos Biopharma priced its shares at $16 to raise $100m and will use proceeds to advance the development of two treatments for inflammatory bowel disease.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NC State is the first of a planned five academic partners to benefit from on-campus commercialisation experts and access to capital.

V-Bio Ventures, the venture firm affiliated with VIB, will focus on healthcare and sustainable agriculture companies primarily in Belgium.

Cambridge and CRUK spinout Inivata has more than doubled its series C round to $60m following a $35m extension backed by IP Group.